- id: rule_allergy_scit_environmental
  name: Environmental Allergen Immunotherapy - Subcutaneous
  description: Prior authorization for subcutaneous immunotherapy (SCIT) for environmental allergies
  type: PRIOR_AUTH
  scope:
    service_types: ["MEDICAL"]
    place_of_service: ["11", "22"]
  conditions:
    all_of:
      - service_code:
          any_of:
          - '95115'
          - '95117'
          - '95144'
          - '95145'
          - '95146'
          - '95147'
          - '95148'
          - '95149'
          - '95165'
          - '95170'
      - diagnosis_code:
          any_of:
          - J30.1
          - J30.2
          - J30.81
          - J30.89
          - J45.909
          - H10.13
          - H10.23
      - any_of:
        - all_of:
          - patient_age:
              min: 5
              max: 65
          - prior_service_within_days:
              service_codes:
              - '95004'
              - '95024'
              - '95027'
              - '95028'
              days: 365
              description: Allergy skin testing within past year
        - all_of:
          - patient_age:
              min: 5
              max: 65
          - prior_service_within_days:
              service_codes:
              - '86003'
              - '86005'
              days: 365
              description: Specific IgE testing within past year
      - none_of:
        - diagnosis_code:
            any_of:
            - J44.0
            - J44.1
            - C78.00
            - D84.9
            - Z87.891
  logic:
    outcome: approved
    reason: Environmental allergen immunotherapy approved for documented allergic rhinitis/asthma with positive testing
  metadata:
    source: UnitedHealth Medical Policy 2025.09
    effective_date: '2025-09-01'
    clinical_rationale: SCIT effective for environmental allergies with documented sensitization
- id: rule_allergy_slit_environmental
  name: Environmental Allergen Immunotherapy - Sublingual
  description: Prior authorization for sublingual immunotherapy (SLIT) for environmental allergies
  type: PRIOR_AUTH
  scope:
    service_types: ["MEDICAL"]
    place_of_service: ["11", "22"]
    conditions:
    all_of:
      - service_code:
          any_of:
          - '95131'
          - '95132'
          - '95133'
          - '95134'
          - '95135'
          - '95136'
          - '95137'
          - '95138'
          - '95139'
      - diagnosis_code:
          any_of:
          - J30.1
          - J30.2
          - J30.81
          - J30.89
          - J45.909
      - patient_age:
          min: 5
          max: 65
      - any_of:
        - prior_service_within_days:
            service_codes:
            - '95004'
            - '95024'
            - '95027'
            - '95028'
            days: 365
            description: Allergy skin testing within past year
        - prior_service_within_days:
            service_codes:
            - '86003'
            - '86005'
            days: 365
            description: Specific IgE testing within past year
      - none_of:
        - diagnosis_code:
            any_of:
            - J44.0
            - J44.1
            - K92.2
            - D84.9
  logic:
    outcome: approved
    reason: Sublingual immunotherapy approved for environmental allergies with documented sensitization
  metadata:
    source: UnitedHealth Medical Policy 2025.09
    effective_date: '2025-09-01'
    clinical_rationale: SLIT approved for grass/ragweed allergies with positive testing
- id: rule_allergy_venom_immunotherapy
  name: Venom Immunotherapy
  description: Prior authorization for venom immunotherapy for insect sting allergies
  type: PRIOR_AUTH
  scope:
    service_types: ["MEDICAL"]
    place_of_service: ["11", "22"]
    conditions:
    all_of:
      - service_code:
          any_of:
          - '95115'
          - '95117'
          - '95144'
          - '95145'
          - '95146'
          - '95147'
          - '95165'
          - '95170'
      - diagnosis_code:
          any_of:
          - T63.441A
          - T63.451A
          - T63.461A
          - Z87.892
          - Z91.038
      - patient_age:
          min: 3
      - any_of:
        - all_of:
          - prior_service_within_days:
              service_codes:
              - '95004'
              - '95024'
              - '95028'
              days: 730
              description: Venom skin testing within past 2 years
          - diagnosis_code:
              any_of:
              - T78.2XXA
              - T78.00XA
              - T88.6XXA
        - all_of:
          - prior_service_within_days:
              service_codes:
              - '86003'
              - '86005'
              days: 730
              description: Venom-specific IgE within past 2 years
          - diagnosis_code:
              any_of:
              - T78.2XXA
              - T78.00XA
              - T88.6XXA
      - none_of:
        - diagnosis_code:
            any_of:
            - I25.10
            - I50.9
            - D84.9
            - C80.1
  logic:
    outcome: approved
    reason: Venom immunotherapy approved for systemic allergic reactions with positive venom testing
  metadata:
    source: UnitedHealth Medical Policy 2025.09
    effective_date: '2025-09-01'
    clinical_rationale: VIT prevents life-threatening anaphylaxis in venom-allergic patients
- id: rule_allergy_food_oit
  name: Food Allergen Immunotherapy - Oral
  description: Prior authorization for oral immunotherapy (OIT) for food allergies
  type: PRIOR_AUTH
  scope:
    service_types: ["MEDICAL"]
    place_of_service: ["11", "22"]
    conditions:
    all_of:
      - service_code:
          any_of:
          - '95180'
          - '95181'
          - '95182'
          - '95183'
          - '95184'
      - diagnosis_code:
          any_of:
          - Z91.010
          - Z91.011
          - Z91.012
          - Z91.013
          - T78.1XXA
          - T78.05XA
      - patient_age:
          min: 4
          max: 17
      - prior_service_within_days:
          service_codes:
          - '86003'
          - '86005'
          - '95004'
          days: 365
          description: Food allergy testing within past year
      - any_of:
        - diagnosis_code:
            any_of:
            - T78.00XA
            - T78.2XXA
            - T88.6XXA
        - prior_service_within_days:
            service_codes:
            - J0171
            - J0172
            days: 1095
            description: Epinephrine use within past 3 years
      - none_of:
        - diagnosis_code:
            any_of:
            - J45.901
            - K90.0
            - D84.9
            - F84.0
  logic:
    outcome: approved
    reason: Food oral immunotherapy approved for documented IgE-mediated food allergy with anaphylaxis history
  metadata:
    source: UnitedHealth Medical Policy 2025.09
    effective_date: '2025-09-01'
    clinical_rationale: OIT reduces anaphylaxis risk in high-risk pediatric food allergy patients
- id: rule_allergy_immunotherapy_monitoring
  name: Immunotherapy Monitoring and Maintenance
  description: Coverage for immunotherapy monitoring visits and maintenance dosing
  type: PRIOR_AUTH
  scope:
    service_types: ["MEDICAL"]
    place_of_service: ["11", "22"]
    conditions:
    all_of:
      - service_code:
          any_of:
          - '99211'
          - '99212'
          - '99213'
          - '95115'
          - '95117'
      - diagnosis_code:
          any_of:
          - J30.1
          - J30.2
          - J30.81
          - J30.89
          - J45.909
          - Z91.010
          - Z91.011
          - Z91.012
          - Z91.013
          - Z87.892
      - prior_service_within_days:
          service_codes:
          - '95144'
          - '95145'
          - '95146'
          - '95147'
          - '95148'
          - '95149'
          - '95131'
          - '95132'
          - '95133'
          - '95180'
          - '95181'
          days: 90
          description: Active immunotherapy within past 90 days
      - utilization_limit:
          per_year: 52
          description: Maximum 52 monitoring visits per year
  logic:
    outcome: approved
    reason: Immunotherapy monitoring approved for patients on active allergen immunotherapy
  metadata:
    source: UnitedHealth Medical Policy 2025.09
    effective_date: '2025-09-01'
    clinical_rationale: Regular monitoring essential for immunotherapy safety and efficacy
